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Abstract 
 
 
Objective: Prolonged partial obstruction (PPO) is a common finding in sleep studies. 
Although not verified, it seems to emerge in deep sleep. We study the effect of PPO on sleep 
architecture or sleep electroencephalography (EEG) frequency. 
Methods: Fifteen OSA patients, 15 PPO+OSA patients and 15 healthy subjects underwent a 
polysomnography. PPO was detected from Emfit mattress signal. Visual sleep parameters and 
median NREM sleep frequency of the EEG channels were evaluated. 
Results: The amount of deep sleep (N3) did not differ between the PPO+OSA and control 
groups (medians 11.8% and 13.8%). PPO+OSA-patients’ N3 consisted mostly of PPO. 
PPO+OSA patients had lighter sleep than healthy controls in three brain areas (Fp2-A1, C4-
A1, O1-A2, p-values < 0.05).  
Conclusion: PPO evolved in NREM sleep and especially in N3 indicating that upper airway 
obstruction does not always ameliorate in deep sleep but changes the type. Even if 
PPO+OSA-patients had N3, their NREM sleep was lighter in three EEG locations. This might 
reflect impaired recovery function of sleep.  
 
 
Keywords: OSA, partial obstruction, Emfit, sleep EEG, flow limitation, sleep-disordered 
breathing, breathing effort 
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Introduction   
 
 
Phenotyping has opened up new ways of evaluating the pathophysiological processes behind 
sleep disordered breathing (SDB) and addressing the treatment options. Different methods to 
phenotype obstructive sleep apnoea (OSA) have been presented. For example, cluster analysis 
has revealed phenotypes associated with position and sleep stages (Joosten et al., 2012).  
 
OSA, assessed using the apnoea-hypopnea index (AHI), is commonly more severe in supine 
position than in other postures (Cartwright, 1984, Pevernagie and Shepard, 1992, Cartwright 
et al., 1991). The pressure at which the pharynx collapses (PCRIT) is found to be higher in 
supine than side position (Boudewyns et al., 2000, Isono et al., 2004, Ong et al., 2011, Penzel 
et al., 2001), and the higher AHI in supine position may be related to anatomical features 
(Isono et al., 2002,Ono et al., 2000,Saigusa et al., 2009), although the findings are not 
consistent (Jan et al., 1994, Walsh et al., 2008, Pevernagie et al., 1995, Martin et al., 1995).  
 
In general, the AHI is higher in rapid eye movement (REM) sleep than in non-REM (NREM) 
sleep (Cartwright et al., 1991, Oksenberg et al., 2010). In addition, the AHI diminishes in 
deep sleep (Ratnavadivel et al., 2009). However, the usefulness of the AHI alone to quantify 
SDB has been criticised because long periods of prolonged partial obstruction without apnoea 
or hypopnea are common in SDB patients (Anttalainen et al., 2016, Tenhunen et al., 2013). 
Prolonged partial obstruction causes flow limitation in the nasal pressure signal (Hernandez et 
al., 2001) and can be assessed quantitatively by measuring oesophageal pressure (see Bao and 
Guilleminault, 2004). One feasible way to evaluate prolonged partial obstruction is the Emfit 
mattress sensor. The sleep mattress signal is usually scored into different breathing categories 
 4 
 
4 
in 3-min epochs. Simply, the mattress signal is divided into three different breathing 
categories: non-obstructive breathing (NOB), periodic obstructive breathing (POB) that 
comprises periodic apnoea and hypopnea, and prolonged partial obstruction (PPO). 
 
Based on our preliminary finding, it seems that PPO manifests during NREM sleep and also 
during deep NREM sleep (Rauhala et al., 2007). The aim of the present study is to clarify the 
appearance of PPO in the sleep stages. In addition, we evaluate whether PPO has an effect on 
the sleep architecture and frequency of NREM sleep electroencephalography (EEG). 
Furthermore, we evaluate the impact of sleeping position on PPO.  
 
2. Methods  
 
All patients were referred to the Sleep laboratory of Tampere University Hospital because of 
possible obstructive sleep apnoea (OSA). The control subjects were healthy volunteers 
recruited through advertisements. The volunteers received no payment for their participation 
in the study. Both patients and controls were first interviewed by telephone to make sure they 
met the eligibility criteria: aged between 20 and 65 years, no (other) sleep disorders, no 
clinically significant medical disorder (e.g., neurological illness, psychiatric disorder, hypo-
/hyperthyroidism and no lung diseases other than currently asymptomatic asthma), no 
medication affecting the central nervous system and no substance or alcohol abuse. The 
patients’ OSA diagnosis and the controls’ healthiness were then confirmed by clinical 
interview and a diagnostic full-night polysomnography in a sleep laboratory. The OSA 
diagnosis was based on a clinical picture and subjective complaints of OSA and an AHI of > 
10/h. The controls had to be asymptomatic and had an AHI of ≤ 5/h. The study was approved 
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by the Ethical Committee of the Pirkanmaa Hospital District and all the subjects gave their 
written informed consent. 
 
Sleep recordings were performed with the Embla N7000 device and Somnologica Studio 
software (Medcare®, Iceland). The recordings comprised six EEG derivations (Fp1-M2, Fp2-
M1, C3-M2, C4-M1, O1-M2, O2-M1), two EOG channels, three electromyogram channels 
(chin and both legs), airflow measured with a thermistor and a nasal pressure transducer, 
thoracic and abdominal respiratory movements, pulse oximetry and position. In addition, an 
Emfit mattress (32 cm x 62 cm x 0.4 cm) was placed under a normal foam mattress below the 
thoracic area of the sleeping subject. The unfiltered Emfit signal was acquired directly as a 
separate trace in the Somnologica software. A sampling rate of 2 Hz was used for the pulse 
oximeter (SpO2 and pulse rate), 10 Hz for respiratory movements and 200 Hz for all the other 
signals.  
 
2.1. Visual analysis 
 
Polysomnographies were classified into sleep stages according to standard criteria (Iber et al., 
2007). The AHI was calculated as the number of obstructive apnoea and hypopnea per hour of 
sleep (Berry et al., 2012). In addition to total AHI, the AHI was calculated separately for 
supine and non-supine positions and for NREM sleep and REM sleep. Arousals were scored 
according to the criteria of the American Sleep Disorders Association (AASM, 1992). 
 
The Emfit signal was visually scored in 3-min epochs into breathing categories as described 
in our previous work (Tenhunen et al., 2013). The mattress breathing categories used were 
non-obstructive breathing (NOB), obstructive periodic breathing (POB), and prolonged partial 
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obstruction (PPO). PPO in Emfit signal is comprised of continuous respiratory-induced 
spikes, which are known to appear with increasing breathing effort (Figure 1, Kirjavainen et 
al., 1996).The Emfit signal was scored visually from a lights off-event to the final awakening 
by two independent scorers with a scoring agreement of 87.8% (median, range 76.9% to 
95.7%). The two independent scorers formed the consensus scoring used in the analyses. The 
percentage of time (referred to as TST) for NOB, POB and PPO were calculated. In addition, 
the number and the length of PPO-periods were calculated. Due to the epoch scoring, the 
minimum length of a PPO-period was 3 min.  
 
Figure 1. Five minutes epoch of deep sleep (N3) with prolonged partial obstruction. Breathing 
is stable, nasal flow signal shows mild flow limitation. Patient is snoring. Continuous spikes 
in the Emfit signal. Oxygen saturation values are normal. 
Channels from top: Thorax belt, Abdomen belt, Airflow by nasal prongs, Snoring, Emfit 
signal, Oxygen saturation, Pulse.    
 
 
In total, 45 OSA patients and 20 control subjects took part in the study. To evaluate the effect 
of prolonged partial obstruction (PPO) on sleep architecture, we formed three age-matched 
groups based on the AHI and amount of PPO-pattern. The OSA group had to have an AHI > 
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10, and time with PPO (as percentage of total sleep time) < 5%. The OSA+PPO group had to 
have an AHI > 10 and PPO > 15%. The subjects in the control group had to have an AHI < 
5/h and PPO < 5%. Fifteen control subjects and 30 patients fulfilled the inclusion criteria, and 
each group comprised 15 male subjects.  
 
2.2 Calculation of EEG median frequency  
 
Mean frequency values were computed from each of the six EEG channels at 1-s time 
resolution by applying the method described in our previous work (Huupponen et al., 2009, 
Huupponen et al., 2011). This provided six overnight mean frequency curves with values 
ranging from 0.5 Hz to 30 Hz. The median of the mean frequency values during the NREM 
sleep time was extracted from each EEG channel.  
 
2.3. Statistical analysis 
 
Statistical analyses were performed with IBM® SPSS® Statistics version 22 (IBM corp.) with 
non-parametric tests because some of the parameters were not normally distributed and the 
sample sizes were small. The Friedman test and Kruskall-Wallis test were used to compare 
the multiple dependent and independent variables, respectively. The post hoc analyses were 
made by using the Wilcoxon and Mann-Whitney U-tests and the comparisons were 
Bonferroni corrected. The probability level of 5% was considered to be significant in the 
statistical tests. 
 
3. Results   
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The demographic data and sleep parameters of the subject groups are presented in Table 1. 
The groups did not differ by age, but the patients in the PPO+OSA group and in the OSA 
group weighted more than the control subjects. Both patient groups presented more daytime 
sleepiness than the controls as assessed by Epworth Sleepiness Scale (ESS).  
 
There were no statistical differences between the groups in the sleep efficiency (SEI) or in the 
amount of N1 or REM sleep. The amount of deep sleep (N3) was diminished in the OSA 
group when compared with the other groups, and N2 sleep was more abundant in the OSA 
group than in the control group. 
 
 
 
 
Table 1. Demographic and polysomnographic data of the groups with the statistical 
comparisons. The statistically significant p-values are bolded. 
 PPO+OSA (1) OSA (2) Controls (3) 1 vs. 2 1 vs. 3 2 vs. 3 
 median min-max median min-max median min-max p-values 
age, years 44 28-65 45 30-63 40 30-63 0.660 0.567 0.193 
ESS 12 9-22 9 5-19 4 0-9 0.779 <0.001 <0.001 
BMI, kg/m2 26.5 24.3-36.3 30.4 23.0-41.4 23.8 20.1-30.2 0.168 0.012 <0.001 
TST, min 426.0 347.5-582.0 437.0 330.0-557.0 442.0 358.0-527.0 1.00 1.00 0.617 
SEI, % 93.0 86.0-99.5 92.0 65.9-96.1 91.0 79.0-98.0 1.00 1.00 1.00 
N1, % 5.9 1.7-10.4 4.9 1.2-18.5 5.4 2.2-16.3 1.00 1.00 0.662 
N2, % 62.5 49.5-80.0 74.8 47.6-85.3 59.5 45.4-71.7 0.064 1.00 0.004 
N3, % 11.8 6.9-22.8 0.6 0.0-15.4 13.8 4.7-25.2 0.001 1.00 0.001 
REM, % 18.0 4.9-26.6 17.4 8.6-21.6 19.4 13.1-27.8 1.00 1.00 0.406 
AHI, n/h 34.0 10.8-48.0 50.9 15.8-103.0 3.0 0.0-4.9 0.103 <0.001 <0.001 
AHI REM, n/h 45.0 7.3-67.0 35.0 27.5-87.5 5.2 0.0-14.8 1.00 <0.001 <0.001 
AHI NREM, n/h 31.1 10-54.4 56.2 12.2-106.0 1.7 0.0-4.6 0.079 <0.001 <0.001 
AHI supine, n/h 44.2 11.3-70.1 75.7 19.0-105.5 2.0 0.0-8.2 0.057 <0.001 <0.001 
AHI non-supine, n/h 26.2 0.0-49.3 39.9 0.0-110.0 0.4 0.0-5.8 0.121 <0.001 <0.001 
ARI, n/h 26.6 9.4-38.0 41.1 15.8-95.1 12.2 4.3-22.8 0.114 0.001 <0.001 
ODI4%, n/h 13.0 0.0-41.0 32.0 1.0-88.0 0.4 0.0-3.0 0.266 <0.001 <0.001 
NOB, % 28.1 3.1-68.9 24.9 0.4-87.0 97.5 85.9-99.3 0.330 <0.001 <0.001 
POB, % 48.0 13.5-66.5 75.1 12.3-99.1 2.1 0.0-12.3 0.330 <0.001 <0.001 
PPO, % 23.4 15.4-36.0 0.0 0.0-4.7 0.0 0.0-4.9 <0.001 <0.001 0.658 
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Abbreviations: ESS = Epworth Sleepiness Scale; BMI = body mass index; TST = total sleep 
time; SEI = sleep efficiency of TST; N1%-N3% = percentage of sleep stage 1-3 referred to 
TST; REM% = percentage of REM sleep referred to TST; AHI = apnea-hypopnea index; ARI 
= arousal index; ODI4% = oxygen desaturation index; NOB = percentage of time with non-
obstructive breathing referred to TST; POB% = percentage of time with periodic obstructive 
breathing referred to TST; PPO% = percentage of time with prolonged partial obstruction 
referred to TST. 
 
 
Median NREM EEG frequency (in Hz) was separately calculated for each EEG channel 
(Figure 2). The EEG frequency was significantly higher in the OSA group than in the 
PPO+OSA group and the controls in all EEG-derivations. In addition, EEG frequency was 
higher in the PPO+OSA group than the controls frontopolarly and centrally in the right 
hemisphere (Fp2, C4) and occipitally in the left hemisphere (O1).   
 
Figure 2. Median NREM EEG frequency in all EEG derivations. The statistically significant 
differences (Bonferroni corrected p-values < 0.05) are marked with lines.  
 
 
3.1. AHI, sleep stages and position 
 
As expected, all the calculated AHIs as well as the desaturation index (ODI4) were lower in 
the control group than in the patient groups (Table 1). In the control group, the AHI in REM 
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sleep (AHI REM) was higher when compared with the AHI in NREM sleep (AHI NREM, 
Table 1, p-value 0.005). The median AHI REM seems higher than the AHI NREM in the 
PPO+OSA group, whereas in the OSA group the median AHI NREM seems higher than the 
AHI REM. The AHI REM/AHI NREM comparisons within these groups did not, however, 
reach statistical significance.  
 
In the PPO+OSA group, the AHI in supine position was higher compared with the AHI in 
non-supine position (p=0.017). No significant differences were found in the OSA group or 
control group (p-values 0.128 and 0.363, respectively).  
 
3.2. Mattress breathing categories with the effect of position 
 
The control group had more non-obstructive breathing (NOB) than the two patient groups, 
whereas no statistical difference in NOB% was obtained between the PPO+OSA and OSA 
groups (Table 1). Both patient groups had more periodic obstructive breathing (POB) than the 
control group. Due to the inclusion criteria, the PPO+OSA group had clearly more prolonged 
partial obstruction (PPO) than the other groups. No difference in the amount of PPO was 
found between the OSA group and the control group. 
 
The total number of PPO-periods in the study sample was 69. PPO+OSA patients had 61 
PPO-periods, the OSA group had 6 PPO-periods and healthy controls 2 PPO-periods. The 
median length of the PPO-periods was 15 min (3 min to 57 min). The PPO-periods of the 
PPO+OSA patients were in general longer than the periods in the OSA and control groups 
(medians 18 min, 4.5 min and 6 min, respectively). However, due to the small number of 
PPO-periods in the OSA and control groups, statistical comparisons could not be performed.  
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The PPO+OSA group had prolonged partial obstruction in both supine and non-supine 
positions (Figure 3). POB was more abundant in supine position and NOB in non-supine 
position. The OSA group had POB more in supine position and more NOB in non-supine 
position. The control subjects had mostly non-obstructive breathing with no position-
dependent differences.   
 
Figure 3. Mattress breathing categories (percentage of time referred to total sleep time) in 
different sleeping positions. Median values are presented. The statistically significant 
differences are marked with lines and denoted with the p-values. 
 
 
3.3. Mattress breathing categories and sleep stages 
 
In N1 sleep, both the PPO+OSA group and the OSA group had more NOB and POB than 
PPO (Figure 4, Table 2), but there was no statistically significant difference between the 
amount of NOB and POB. The control group had mostly NOB, and the least common 
breathing category was PPO. 
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Figure 4. The appearance of mattress breathing categories (in minutes, median values) of the 
study groups in different sleep stages. Please note the different time scales. 
 
 
In N2 sleep, the PPO+OSA group had more POB than PPO, with no other significant 
findings. OSA patients had more NOB and POB than PPO. The control group had mostly 
normal breathing, and PPO was the least common breathing category.  
 
During N3 sleep, the most common breathing category in the PPO+OSA group was PPO. The 
OSA group had more NOB than PPO, but the other differences did not reach statistical 
significance. NOB was the most common breathing category in the control group during N3.  
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In REM sleep, both the PPO+OSA group and the OSA group had more NOB and POB than 
PPO, but the amount of NOB did not differ from POB. NOB was the most common breathing 
category, and PPO was the least common breathing category in the controls.  
 
 
Table 2. The p-values of the comparisons between the breathing categories in different sleep 
stages. 
  
NOB vs POB NOB vs PPO POB vs PPO 
  
p-value p-value p-value 
N1 OSA+PPO 1.000 0.008 0.003 
 
OSA 0.473 0.010 0.002 
 
Controls 0.002 0.002 0.023 
N2 OSA+PPO 0.634 0.920 0.006 
 
OSA 0.768 0.011 0.002 
 
Controls 0.002 0.002 0.039 
N3 OSA+PPO 0.594 0.003 0.002 
 
OSA 0.181 0.040 1.000 
 
Controls <0.001 0.001 0.539 
REM OSA+PPO 0.183 0.028 0.003 
 
OSA 0.107 0.023 0.002 
 
Controls 0.002 0.002 0.027 
NOB, non-obstructive breathing; POB, periodic obstructive breathing; PPO, prolonged partial 
obstruction. 
 
 
4. Discussion 
 
In this study, we evaluated the appearance of prolonged partial obstruction (PPO) in sleep 
stages and found that in OSA patients with prolonged partial obstruction (PPO+OSA) PPO is 
solely a NREM sleep phenomenon, emerging especially in deep sleep. The other important 
finding was that some OSA patients have a lot of deep sleep without apnoea, but with 
prolonged upper airway obstruction. 
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In our study, the amount of deep sleep of OSA patients remained low, which is a common 
finding. In the PPO+OSA group, however, the amount of visually scored slow wave sleep 
was high and did not differ from the amount of N3 of the normal controls. To the best of our 
knowledge, the effect of PPO on sleep architecture and sleep EEG in OSA patients has not 
been previously evaluated. The cumulative increase in transcutaneous carbon dioxide tension 
during PPO but not during periodic apnoea (Rauhala et al., 2007, Rimpila et al., 2014) might 
be responsible for the greater share of N3 in PPO+OSA patients, since hypercapnia is known 
to increase deep sleep (Halpern et al., 2003, Wang et al., 2014, Nguyen et al., 2016). 
However, PPO+OSA patients had lighter sleep than the control group in three EEG-
derivations. Our results suggest that the sleep process might be impaired in PPO+OSA 
patients even if their visual sleep stage values were within normal ranges. In our study 
protocol, the effects of OSA hampered the EEG conclusions. Therefore, a future study that 
includes patients with prolonged partial obstruction without OSA should be conducted. 
 
The PPO+OSA group had a higher AHI in supine position than in non-supine position, but the 
criteria of positional OSA were not fulfilled. Furthermore, sleeping position had no effect on 
the amount of PPO in PPO+OSA patients. No clear differences between the AHI in NREM 
and REM sleep were obtained in the patient groups. This suggests that PPO has no marked 
association with either the supine predominant or the REM sleep predominant phenotypes of 
OSA, and there have to be additional factors that account for the building of prolonged partial 
obstruction during sleep. Eckert (2018) presents SDB phenotypes that take into account 
several anatomical and non-anatomical features of OSA. The first feature is the stability of 
respiratory control, which can be estimated using the concept of loop gain. Loop gain denotes 
the strength of the negative feedback loop, where a disturbance in breathing (for example 
apnoea with hypoxia/hypercapnia) induces a corrective response (hyperventilation). If loop 
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gain is high, the correction reaction is excessive leading to oscillating breathing and recurrent 
apnoea. The association between loop gain and position is not consistent (Joosten et al., 
2015), but in some OSA patients high loop gain seems to persist during almost the whole 
night, as was the case with our OSA-patients who had respiratory events regardless of their 
position. 
 
Normal loop gain predisposes to stable breathing resulting in eucapnia (Hernandez and Patil, 
2016). Hypoventilation with an increase in carbon dioxide tension may occur if loop gain is 
low (Eckert, 2018). Because prolonged partial obstruction presents with a cumulative increase 
in carbon dioxide concentration (Rimpila et al., 2014, Rauhala et al., 2007) without oscillating 
breathing (Tenhunen et al., 2011, Rauhala et al., 2007), it is assumed that in PPO+OSA 
patients, for some reason, loop gain lowers inducing PPO. In general, our PPO+OSA patients 
were only mildly obese, and therefore this phenomenon cannot be considered as obesity 
hypoventilation.  
 
The second feature that Eckert introduced was arousal threshold that reduces in deep sleep 
(Eckert, 2018), and it has been reported that some OSA patients can achieve deep sleep 
without apnoea (Ratnavadivel et al., 2009). In fact, our OSA group had non-obstructive deep 
sleep, even if its amount remained low. Instead, the patients with PPO+OSA had plenty of 
deep sleep and one of our main findings was that their deep sleep was not free from upper 
airway obstruction but consisted mostly of prolonged partial obstruction. This means that in 
these patients SDB did not recover in deep sleep but changed type. It might be that the 
decrease in arousability during deep sleep predisposes some patients to prolonged partial 
obstruction, which is in accordance with the finding that arousals are infrequent during 
prolonged partial obstruction (Tenhunen et al., 2011, Rauhala et al., 2007).  
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Eckert’s third feature (Eckert, 2018) is the neuromuscular function of the upper airway. 
Genioglossus activity is high during deep sleep compared with other sleep stages (Carberry et 
al., 2016). This might, in part, explain the occurrence of deep sleep in OSA patients. PPO is 
common in females, but the findings have not been consistent. However, hormonal regulation 
might play a role in PPO, since progesterone is known to stimulate respiration and increase 
genioglossus activity (Porkka-Heiskanen et al., 2014, Popovic and White, 1998). 
Furthermore, anatomical features might predispose to the emergence of prolonged partial 
obstruction. For example, micrognathia is found to be more common in women with PPO 
than in women with OSA (Anttalainen et al., 2013), and patients with PPO+OSA have been 
found to have narrower airways at the hypopharyngeal level than OSA patients (Polo et al., 
1991). Moreover, flow limitation is associated with abnormal nasal structure and voluminous 
upper airway lateral wall (de Godoy et al., 2015). 
 
Prolonged partial obstruction can last from several minutes up to about an hour, as in our 
study. During PPO, breathing prevails against a partially closed upper airway, airflow 
diminishes, snoring is often continuous and breathing effort increases. Evaluating flow 
limitation measured by nasal pressure transducer signal, which is considered as a marker of 
partial collapse in upper airways, is a more common method to quantify partial obstruction 
than the Emfit signal that is used in our study (Hernandez et al., 2001, Bao and Guilleminault, 
2004, Johnson et al., 2005, Sabil et al., 2004, Condos et al., 1994). Measuring flow limitation 
is, however, problematic since nasal prongs may even increase upper airway resistance 
(Lorino et al., 2000), and obstruction may prevail without flow limitation (Tenhunen et al., 
2011). Moreover, flow limitation is not always caused by upper airway obstruction (Condos 
et al., 1994), but instead may indicate a decrease in breathing effort (Arora et al., 2015). A 
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simultaneous increase in transcutaneous carbon dioxide with flow limitation confirms its 
obstructive nature (Rimpila et al., 2014), but carbon dioxide is not always routinely measured 
in sleep studies. The Emfit mattress measures breathing effort (Tenhunen et al., 2011, 
Kirjavainen et al., 1996) and provides an additional easy and noninvasive means to quantify 
different types of sleep disordered breathing. 
 
Prolonged partial obstruction is often considered to be a milder form of SDB than OSA, even 
if the patients may have severe symptoms, such as fatigue, depressive symptoms, morning 
headache and decreased quality of life (Anttalainen et al., 2016). Our study cannot address 
why some patients have PPO. We can, however, show that even if patients with PPO+OSA 
are as sleepy as OSA patients, they have more N3. They also have deeper sleep than OSA 
patients in all EEG derivations. Moreover, they present with lighter sleep than healthy 
controls in the same EEG derivations that show a reduced amount of slow EEG frequencies in 
OSA patients with six months of CPAP treatment (Saunamaki et al., 2009). Poor quality sleep 
might explain some of the subjective symptoms of PPO patients. In addition, the increased 
inspiratory effort related to PPO may induce sleepiness (Pelin et al., 2003). In general, PPO 
patients present with good adherence to CPAP treatment (Anttalainen et al., 2007, Myllyla et 
al., 2016).  
 
Phenotyping provides improved understanding of the mechanisms and treatment options for 
SDB. Prolonged partial obstruction results in different findings than OSA; it emerges in deep 
sleep, carbon dioxide tension increases cumulatively, and it is not composed of arousals. 
Medications that reduce the arousal threshold (Eckert et al., 2011) are not expected to be 
useful in this SDB phenotype with infrequent arousals (Tenhunen et al., 2011). Moreover, 
reducing the arousal threshold might even be unsafe, as in obesity hypoventilation (Jordan et 
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al., 2017). Treatments that reduce loop gain, such as oxygen therapy (Wellman et al., 
2008,Terrill et al., 2015), do not seem to be the correct choice either. Instead, oropharyngeal 
exercise (Camacho et al., 2015), drugs that increase muscle activity (Taranto-Montemurro et 
al., 2016) and upper-airway stimulators (Boon et al., 2018) could be helpful. However, if they 
only remove respiratory events and prolonged partial obstruction remains, there might be a 
risk of an excessive increase in carbon dioxide. We therefore suggest that, in addition to 
common respiratory parameters, the detection of prolonged partial obstruction may be useful 
in evaluating sleep disordered breathing and in making treatment decisions.  
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